Sanders Morris Harris LLC Bluebird Bio, Inc. Transaction History

Sanders Morris Harris LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$2.94 - $5.23 $37,632 - $66,944	-12,800 Closed	0 $0
Q1 2022 Apr 11, 2022	BUY	$4.07 - $10.6 $52,096 - $135,680	12,800 New	12,800 $62,000
Q1 2021 Apr 14, 2021	SELL	$16.59 - $33.89 $106,176 - $216,896	-6,400 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$27.5 - $37.92 $13,750 - $18,960	500 Added 8.47%	6,400 $317,000
Q3 2020 Oct 16, 2020	BUY	$34.44 - $43.75 $15,497 - $19,687	450 Added 8.26%	5,900 $337,000
Q2 2020 Jul 09, 2020	BUY	$27.12 - $45.97 $147,804 - $250,536	5,450 New	5,450 $333,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Sanders Morris Harris LLC, based on Form 13F filings with the SEC.

Stay updated on Sanders Morris Harris LLC with notifications on news.